Injection Pen Global Market Report 2025

Injection pens are utilized to administer medication beneath the skin. They offer a more convenient and user-friendly method for delivering injectable medications like insulin, thereby enhancing patient compliance. These pens typically comprise a cartridge, a dosage measurement dial, and a disposable needle, providing a simpler, more accurate, and convenient alternative to using a vial and syringe.

The primary categories of injection pens include disposable and reusable variants. Disposable injection pens feature a non-replaceable prefilled cartridge that is discarded after use. On the other hand, reusable injection pens come with a replaceable cartridge that can be swapped out. Injection pens find application in a range of medical purposes, including diabetes, fertility treatments, osteoporosis, growth hormone therapy, and other therapies. They are employed by various end-users, including home care settings, hospitals, and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The injection pen market research report is one of a series of new reports from The Business Research Company that provides injection pen market statistics, including injection pen industry, global injection pen market size, regional shares, competitors with injection pen market share, detailed injection pen market segments, market trends and opportunities, and any further data you may need to thrive in the injection pen industry. This injection pen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The injection pen market size has grown strongly in recent years. It will grow from $57.05 billion in 2024 to $61.17 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increase in need for diabetes management, increased patient preference, reduced needle phobia, improved dosage accuracy, increased aging population.

The injection pen market size is expected to see rapid growth in the next few years. It will grow to $93.19 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to rising diabetes prevalence, rising biologics and biosimilars, rising need for personalized medicine, need for home healthcare, increasing emerging markets. Major trends in the forecast period include smart injection pens, digital health integration, wearable devices, improved user interface, autoinjector compatibility.

The forecast of 11.1% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on dose-counter mechanisms and precision-molded pen components, sourced from key regions such as Denmark and Sweden, which could lead to diabetes treatment challenges and increased expenses for insulin delivery systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the injection pen market is being fueled by the increasing prevalence of diseases like diabetes and arthritis. Factors such as the expanding population affected by obesity, sedentary lifestyles, unhealthy dietary habits, and advancing age have contributed to the global rise in diabetes cases. According to the International Diabetes Federation (IDF), it is projected that the global population with diabetes will reach approximately 640 million by 2040. In emerging countries like India, around 69 million individuals have diabetes, and this number is anticipated to climb to 100 million by 2030. Consequently, the surge in diseases like diabetes and arthritis is expected to be a driving force for the injection pen market.

The rising prevalence of obesity is anticipated to drive the growth of the injection pens market in the future. Obesity is a medical condition defined by an excess of body fat that can adversely affect an individual's health. Injection pens are utilized for obesity management, offering precise and adjustable dosing for medications such as insulin and allowing injections in specific areas for individuals with obesity. For example, data from 2022 released by the Centers for Disease Control and Prevention (CDC), a US government agency, shows that 22 states now have an adult obesity prevalence of 35% or higher, an increase from 19 states in 2021. Consequently, the growing prevalence of obesity is fueling the growth of the injection pens market.

Technological advancements represent a notable trend in the injection pen market. Companies in this sector are prioritizing product innovation and the development of efficient delivery systems. These technological strides facilitate precise medication delivery, enhance patient satisfaction and adherence, and improve overall usability. For instance, in September 2022, Medtronic, a US-based medical technology company, introduced InPen integrated with real-time Guardian Connect CGM data. This integrated solution consolidates crucial diabetes management information, including real-time glucose levels and insulin dosing, into a single screen, simplifying decision-making for users.

Major players in the injection pen market are dedicated to introducing innovative products like Wegovy to provide dependable services to customers. Wegovy, administered through an injection pen, is designed for treating patients dealing with obesity and weight loss. In September 2023, Novo Nordisk A/S, a Denmark-based pharmaceutical company, launched Wegovy. This injection pen contains the drug semaglutide, assisting patients in achieving a body weight reduction of approximately 15% when combined with exercise and lifestyle modifications.

In September 2023, Abbott Laboratories, a US-based medical devices company, acquired Bigfoot Biomedical Inc., bolstering its presence in the diabetes care sector with advanced glucose monitoring technology. This strategic move aims to develop user-friendly, cost-effective tools for individuals managing diabetes. Bigfoot Biomedical Inc., headquartered in California, is a medical technology company specializing in smart injection pens.

Major companies operating in the injection pen market include Novo Nordisk A/S, Ypsomed Holding AG, Sandoz Inc., Eli Lilly and Company, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Owen Mumford Ltd., Sulzer Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Ltd., Wockhardt Ltd., AptarGroup Inc., Novartis AG, Gerresheimer AG, SHL Medical AG, Boehringer Ingelheim International GmbH, Nemera France SA, Companion Medical Inc., Jiangsu Delfu Medical Devices Co. Ltd., Haselmeier GmbH, GlaxoSmithKline plc., Stat Medical Devices Inc., DuPont de Nemours Inc., Emperra GmbH E-Health Technologies, Biocon Limited, Becton Dickinson and Company, Mylan N.V., Terumo Corporation, West Pharmaceutical Services Inc., Bespak Europe Ltd., Mitsubishi Gas Chemical Company Inc., Nipro Corporation, Zogenix Inc., Consort Medical plc

North America was the largest region in the injection pen market in 2024. The regions covered in the injection pen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the injection pen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The injection pen market consists of sales of disposable injection pens and reusable injection pens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injection Pen Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on injection pen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injection pen ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injection pen market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Disposable Injection Pens; Reusable Injection Pens
• 2) By Therapy: Diabetes; Fertility; Osteoporosis; Growth Hormone Therapy; Other Therapies
• 3) By End Users: Home Care; Hospital And Clinics
• Subsegments:
• 1) By Disposable Injection Pens: Pre-filled Disposable Injection Pens; Single-Use Disposable Injection Pens
• 2) By Reusable Injection Pens: Refillable Injection Pens; Multi-Use Injection Pens; Rechargeable Injection Pens
• Companies Mentioned: Novo Nordisk A/S; Ypsomed Holding AG; Sandoz Inc.; Eli Lilly and Company; Merck KGaA; AstraZeneca plc; F. Hoffmann-La Roche Ltd.; Owen Mumford Ltd.; Sulzer Ltd.; Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; Lupin Ltd.; Wockhardt Ltd.; AptarGroup Inc.; Novartis AG; Gerresheimer AG; SHL Medical AG; Boehringer Ingelheim International GmbH; Nemera France SA; Companion Medical Inc.; Jiangsu Delfu Medical Devices Co. Ltd.; Haselmeier GmbH; GlaxoSmithKline plc.; Stat Medical Devices Inc.; DuPont de Nemours Inc.; Emperra GmbH E-Health Technologies; Biocon Limited; Becton Dickinson and Company; Mylan N.V.; Terumo Corporation; West Pharmaceutical Services Inc.; Bespak Europe Ltd.; Mitsubishi Gas Chemical Company Inc.; Nipro Corporation; Zogenix Inc.; Consort Medical plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.